Omicron variant Neutralizing Antibodies Following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 Bivalent Vaccination in Patients with End-Stage Kidney Disease

This dataset contains serologic data on patients receiving hemodialysis or kidney transplant recipients prior to and 1 month following receipt of either the BNT162b2 (BA.4/BA.5) or mRNA-1273 (BA.1) bivalent COVID-19 vaccine. Neutralization against wild-type SARS-CoV-2, Omicron BA.1, BA.5, BQ.1.1, and XBB.1.5 were measured.